Rishab Ramapriyan, MD (@rishabrama) header
Rishab Ramapriyan, MD (@rishabrama) profile picture

Neurosurgery Resident @PennNSG | MD @HarvardMed | BS @RiceUniversity | Passionate about brain tumors, immunotherapy, cell therapy, bioethics

Philadelphia, PA
Joined September 2013
Photo by Rishab Ramapriyan, MD (@rishabrama)Photo by Rishab Ramapriyan, MD (@rishabrama)Photo by Rishab Ramapriyan, MD (@rishabrama)Photo by Rishab Ramapriyan, MD (@rishabrama)Photo by Rishab Ramapriyan, MD (@rishabrama)Photo by Rishab Ramapriyan, MD (@rishabrama)Photo by Rishab Ramapriyan, MD (@rishabrama)Photo by Rishab Ramapriyan, MD (@rishabrama)
🚨1/8 Excited to share the final version of our #meningioma #mesothelin #CART-cell paper, now published @NeuroOnc with corrected proofs! This preclinical work lays the foundation for applying CAR T-cell therapy to aggressive and treatment-refractory meningiomas. Highlights ⬇️
3
16
1
92
8,274
Rishab Ramapriyan, MD retweeted
Thanks to a transformational gift from John and Rosanna Troiano, the Troiano Brain Tumor Center has been established at Penn Medicine. This $35 million initiative launches a bold new phase of innovative brain tumor research and care. ➡️ spr.ly/6018BHoC6k
1
5
26
1,436
Rishab Ramapriyan, MD retweeted
Thank you to my mentors @halpernc, Bijan Pesaran (@pesaranlab), and Michael Beauchamp, to @DanielYoshor and everyone at @PennNSG, staff and residents included. And to my patients, who trust us with the hardest problems. This one is for you. @NINDS #BCI
Congratulations to @iahncajigas on being awarded a 5-year, $3.1M @NIH R01 grant for the proposal, "Microscale Spatial and Temporal Dynamics Of Premotor And Motor Cortex For Enabling Brain Computer Interface Based Motor Restoration Of Arm and Hand Function."
7
6
2
82
3,660
Rishab Ramapriyan, MD retweeted
Interested in a career in neurosurgical oncology? Join the AANS/CNS Joint Section on Tumors Resident Subcommittee at #CNS2026 for our Fellowship Meet & Greet. 📅 Nov 1 | 8:15–10:45 PM 📍 Flight Club DC 🎟️ FREE registration Register: rebrand.ly/TSCNS2026
8
1
10
716
Rishab Ramapriyan, MD retweeted
🚨 E-bike injuries are on the rise! Drs. @JohnMaaMD and Blake Taylor discuss the case of Amelia Stafford, a 15-year-old who survived a devastating e-bike accident and went on to inspire new legislation to prevent more injuries like hers. Learn why e-bikes behave more like mopeds than bicycles, how helmet use and speed drive traumatic brain injury risk, and how physicians can push for change. And stick around for Dr. Maa's update on new laws in California, New Jersey, and beyond! youtu.be/j41ivQQ3AyQ?si=KX1X… #neurosurgery #meded #neurotrauma @AANSNeuro @AANSNeurosurg @NeurosurgUCSF @UCSFSurgery @AmCollSurgeons @UMneurosurgery @AANSCNStrauma @JPGK_MD @councilsns @neurosurgery @CaNeuroSurgeons @DrDiGiorgio
6
3
16
8,993
Rishab Ramapriyan, MD retweeted
Our residents led us through a fantastic clinical conference this morning where we discussed some very interesting cases that happened at each of our hospitals recently.
5
1
39
7,449
Register today!
🚨 TUMOR WARS III: Neuro-Onc Jeopardy 🧠⚡ The showdown returns! Med students, residents & fellows will compete in a fast-paced neuro-onc Jeopardy battle. 👉 Register: forms.gle/pY27qDL6pVb9XsMo9
6
505
Rishab Ramapriyan, MD retweeted
In 2025, Keytruda (pembrolizumab) was the number one drug for global sales ~$32 billion, targeting PD-1, for cancer immunotherapy. But we didn't know precisely how it works until today @ScienceMagazine science.org/doi/10.1126/scie… science.org/doi/10.1126/scie…
16
201
15
857
96,027
Rishab Ramapriyan, MD retweeted
Great run up the Rocky steps this morning w/ some of our subis! @PennNSG @visishs @rishabrama
1
4
23
2,281
Rishab Ramapriyan, MD retweeted
Incredibly excited to share the first major paper from my lab @carnevale_lab led by postdoc Qi Liu @GladstoneInst @UCSF executing the first ever genome-wide in vivo screens for genetic modifications to enhance human T cell therapies for solid tumors. Now in @Nature: nature.com/articles/s41586-0…
16
56
10
328
43,051
Rishab Ramapriyan, MD retweeted
Published this week @NatureMedicine, B7-H3 CAR T cells show promise in patients with rGBM! Congrats to all authors for another big step forward for our field. nature.com/articles/s41591-0…
3
19
102
12,221
Rishab Ramapriyan, MD retweeted
Less than 24 hours to go. In the early AM we start our ascent on Mt. Whitney, the highest peak in the lower 48. As a cerebrovascular neurosurgeon at @PennMedicine @PennNSG, I'm climbing to raise #aneurysm awareness and support @bafound. Help our cause: bit.ly/4pQkgEU
2
4
29
2,801
Rishab Ramapriyan, MD retweeted
Congrats to our Neurosurgery Department award winners for this year! @JohnDArenaMD - Resident Clinical Achievement Award and Resident Research Award @visishs - Faculty Rising Star Award Dr. Eric Zager - Outstanding Faculty Educator Award
1
6
37
5,295
Really exciting work from the #Binder/@DrORourke2 group @PennNSG + collaborators highlights how intracerebroventricular CAR-T doesn’t exert anti-tumor effects in isolation but is heavily influenced by the balance of specific cell populations in the CSF.
Remarkable correlative biology defining responders and non-responders to bivalent #GBM #CART cells from our group at @PennCancer @PennMedicine @KitePharma sciencedirect.com/science/ar…
1
7
26
5,719
Rishab Ramapriyan, MD retweeted
Now that's a good-looking group! 📸 Check out the new team photo for the @PennMedicine Department of Neurosurgery
1
13
52
4,223
Rishab Ramapriyan, MD retweeted
RIP @ProfRAScolyer. A brilliant scientist, physician, and extraordinary human being. His willingness to turn his own #GBM diagnosis into a scientific mission inspired the cancer community worldwide. So much more work remains to be done. #Glioblastoma bbc.com/news/articles/c14yz5…
10
1
85
3,536
🚨NEW @NEJM CAR T cells expanding applications! Here CAR T facilitate kidney transplantation in highly sensitized people. dual CD19 + BCMA CAR T enabled kidney transplantation in two highly sensitized patients after reducing anti-donor antibody barriers, with no severe CRS/neurotoxicity. Another CAR T 1st @PennMedicine
3
17
1
53
9,062
One and done gene therapy for high cholesterol? More data needed but IMHO this is the type of paper that will be taught for years to come. In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia | New England Journal of Medicine nejm.org/doi/full/10.1056/NE…
1
5
25
1,804
Rishab Ramapriyan, MD retweeted
🧵1/3 Delighted that a scientific dream became reality today with the online publication @NatureComms, "Personalized machine learning-guided radiation dose escalation in newly diagnosed #glioblastoma: prospective pilot study" In an age of AI-everything, this pioneering work @PennCancer @PennRadiology @PennRadOnc @PennNSG from the original Penn Neuro-Oncology Translational Center of Excellence (TCE) could, if validated, could be a game-changer in our approach to #RT of #gliomas, improving survival by harnessing #ML and #AI to predict --- and #PPRT to delay --tumor recurrence, rather than simply focusing #RT on the tumor bed. nature.com/articles/s41467-0…
1
9
1
16
2,164
Rishab Ramapriyan, MD retweeted
CTE cannot be diagnosed during life. Our work published today in @NatureMedicine demonstrates that most individuals meeting proposed clinical criteria do not have evidence of #CTE neuropathology at autopsy (1/5) rdcu.be/fiFKk @PennNSG @PennMedCSO @WillStewNeuro
5
27
5
78
14,329